SimPharma

  • Home
  • News & Publications
  • Contact
  • Home
  • News & Publications
  • Contact
SimPharma is an early stage biopharma company based in Singapore. We are developing des-aspartate-angiotensin I (DAA-I), ​a potentially revolutionary treatment for inflammation-linked diseases.
Copyright SimPharma Pte. Ltd. 2016-20